Wipro has entered into partnership with IP Infusion, a leader in disaggregated network solutions, to jointly develop offerings that enable faster innovation in IP and optical networks. Through this partnership, Wipro and IP Infusion will empower original design manufacturers (ODMs), original equipment manufacturers (OEMs), and communication service providers (CSPs) to operate more effectively while reducing CapEx and OpEx.
Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the United States Food and Drug Administration (US FDA). Cipla’s Difluprednate Ophthalmic Emulsion 0.05% is AB-rated generic therapeutic equivalent version of Novartis Pharmaceutical Corporation’s Durezol.
Force Motors has registered a sales growth of 172% in the domestic market and 243% in exports during April - July 2021. The company sold (domestic plus exports) 6,486 units in the period April to July 2021 as compared to 2,311 units sold in the first four months of the previous year. The company continued to consolidate its leadership position in the Large Vans segment. It witnessed growth on the back of bulk purchases of its Ambulance range made by various state governments, hospitals and service providers to enhance the healthcare infrastructure.
Mangalam Drugs & Organics has entered into a Technology Transfer Agreement with a $70 Million leading pharmaceutical company / group in Nigeria, Africa region, for providing them in-house developed technology. The Company will provide an in-house developed technology for manufacturing certain Anti-Malaria Active Pharmaceutical Ingredients (APIs) on limited, nontransferable and exclusive license basis for certain agreed territory. The Company will also provide consultation and relevant designs for setting up an API manufacturing facility for manufacturing of the said APIs, for which the Company is one of the leading manufacturers. It is expected to be a world class API facility and one of its kind in Africa region.
ITC has extensively reset its strategy and will explore opportunities to craft disruptive business models to set up structural drivers helmed by digital and sustainability for its next horizon of growth and make the company future-ready.
PNB Housing Finance is planning to raise funds by way of debt issue and the shareholders are being requested to authorise the board of directors to offer, from time to time, the subscription of redeemable, secured/unsecured non-convertible debentures aggregating to Rs 35,000 crore in one or more tranches. The company will seek shareholders' nod in its annual general meeting (AGM) on September 3, 2021.
Bombay Stock Exchange (BSE) has introduced a new surveillance measure for certain stocks having a market capitalization of less than Rs 1,000 crore to curb excessive volatility in mid and small-cap counters. The new measure, add-on price band framework, will be applicable to companies with a market-capitalization of less than Rs 1,000 crore and on securities in groups -- X, XT, Z, ZP, ZY, and Y.
| Company Name | CMP |
|---|---|
| Ashok Leyland | 174.75 |
| Force Motors | 22382.80 |
| Olectra Greentech | 1226.25 |
| Tata Motors | 439.15 |
| SML Mahindra | 4317.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: